share_log

HC Wainwright & Co. Reiterates Buy on OptiNose, Maintains $5 Price Target

Benzinga ·  Nov 13, 2024 20:30  · Ratings

HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Buy and maintains $5 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment